We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
283 hedge funds and large institutions have $7.08B invested in Madrigal Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 95 increasing their positions, 77 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
81% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 37
48% more capital invested
Capital invested by funds: $4.77B → $7.08B (+$2.31B)
23% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 77
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
10% more call options, than puts
Call options by funds: $354M | Put options by funds: $321M
10% more funds holding
Funds holding: 257 → 283 (+26)
0.81% more ownership
Funds ownership: 104.43% → 105.25% (+0.81%)
Holders
283
Holders Change
+26
Holders Change %
+10.12%
% of All Funds
3.73%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.13%
New
67
Increased
95
Reduced
77
Closed
37
Calls
$354M
Puts
$321M
Net Calls
+$33.1M
Net Calls Change
-$10.2M
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$75.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$40.8M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$39M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$29.9M |
